-

Krista Kelley Named Senior Vice President, Sales and Marketing for MedImpact

Industry veteran to lead the effort by the largest independent PBM to deliver innovation, competition, and choice to government and commercial payers

SAN DIEGO--(BUSINESS WIRE)--MedImpact today announced that Krista Kelley, a 20+ year healthcare industry veteran, has been named Senior Vice President, Sales and Marketing.

“This is an exciting time at our company – we are entering new markets and launching new solutions – and we are thrilled to have Krista represent us in the marketplace,” said MedImpact Chairman and CEO Fred Howe. “She is an experienced pro and inspiring leader who lives the values that define our company: integrity, respect, hard work, and a passion for helping others.”

Krista joined MedImpact in 2018, and quickly rose through the ranks to her most recent role as Vice President, Sales and Strategic Relations. In that time, she has been instrumental in entering agreements with countless government, commercial, higher education, and Taft-Hartley health plans to deliver MedImpact pharmacy benefit management solutions. Previously, she held senior positions at Express Scripts and Merck-Medco. Krista is on the board of Helping our Women, a Massachusetts-based nonprofit dedicated to providing food, financial, and transportation assistance for women with chronic, life threatening and disabling conditions.

For 30 years, MedImpact has invested in building a world-class clinical team, leading the way in innovation, and providing high-touch member services. It is an approach that delivers forward-thinking utilization management, higher levels of member engagement, and low year-over-year trend. Today, MedImpact is the largest independent PBM, serving government and commercial health plans and self-insured employers, and 55 million consumers globally.

“In a market in which large, publicly held healthcare conglomerates are trying to crowd out competition and limit choices, MedImpact is the PBM with the scale, clinical expertise, and technology to provide payers – especially those with complex needs – a real alternative,” said Kelley. “The market is looking for us to compete on every level and our entire company is inspired by this mission.”

About MedImpact

For 30 years, MedImpact has been building, delivering, and reimagining pharmacy benefit solutions for healthcare payers who face complex and dynamic challenges. As the leading independent PBM, we offer clients the clarity they need to make care and cost decisions; control over a powerful suite of solutions that manage pharmacy spend; and confidence that comes from a proven PBM partner who is fully aligned with their goals and invested in their future. Learn more at www.medimpact.com or follow us on Twitter @MedImpact.

MedImpact


Release Versions

More News From MedImpact

MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this biosimilar (adalimumab-ryvk), manufactured by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., through its preferred partner, Birdi Inc., to any hospital, plan, or pharmacy nationwide—not just its own clients or affiliates. “For too long, the industry has used supply chain complexity to inflate...

MedImpact Completes Acquisition of Sav-Rx

SAN DIEGO--(BUSINESS WIRE)--MedImpact Healthcare Systems, Inc., the nation’s largest independent pharmacy benefit and health solutions company, today announced the completion of its acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. The transaction strengthens MedImpact’s ability to serve a broad range of clients by adding specialized expertise, scale, and deep insight into a key market segment. Sav-Rx will continue to operate in...

MedImpact Unveils Innovative PMPM Guarantee Model

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefits technology and health solutions provider, today announced the launch of MedImpact OnePrice™, a new approach to prescription drug cost containment that offers clients a predictable, transparent, and performance-backed Per Member, Per Month (PMPM) pricing model. Unlike other guarantees on the market, MedImpact stands firmly behind its commitment—putting its entire administrative fee at risk to ensure clients...
Back to Newsroom